Dr Agarwal's Eye Hospital Reports Strong Growth Amid Rising Interest Costs in March 2025 Results

Dr Agarwal's Eye Hospital has recently reported its financial results for the quarter ending March 2025, showcasing notable developments in its performance metrics. The company's score has undergone a revision, reflecting a shift in evaluation over the past three months.
In terms of financial highlights, Dr Agarwal's Eye Hospital achieved net sales of Rs 99.83 crore, marking a year-on-year growth of 23.67%. This positive trend in sales is complemented by an operating profit (PBDIT) of Rs 31.59 crore, the highest recorded in the last five quarters, indicating enhanced operational efficiency. The operating profit margin also reached a peak of 31.64%, further underscoring the company's improved performance.

Profit Before Tax (PBT) stood at Rs 18.50 crore, with a year-on-year increase of 24.33%. Additionally, the Profit After Tax (PAT) was reported at Rs 15.99 crore, reflecting a growth of 25.0% compared to the previous year. The earnings per share (EPS) also reached a high of Rs 34.02, suggesting a favorable outcome for shareholders.

However, the financial results also highlighted a rise in interest costs, with interest expenses increasing by 51.09% over the preceding nine months, indicating a potential concern regarding increased borrowings.

For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.